Table 2. The improvement of immunoscore-based prognostic nomogram in predicting DFS according to NRI and IDI.
| DFS | Immunoscore-based prognostic nomogram vs. MI |
Immunoscore-based prognostic nomogram vs. TNM stage |
Immunoscore-based prognostic nomogram vs. LMR |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRI (95%CI) | P | IDI (95%CI) | P | NRI (95%CI) | P | IDI (95%CI) | P | NRI (95%CI) | P | IDI (95%CI) | P | |||
| 1-year | 0.646 (0.404–0.799) |
0.004 | 0.031 (0.002–0.071) |
0.042 | 0.567 (0.364–0.712) |
<0.001 | 0.110 (0.062–0.181) |
<0.001 | 0.611 (0.266–0.761) |
<0.001 | 0.106 (0.061–0.176) |
<0.001 | ||
| 3-year | 0.458 (0.311–0.607) |
0.006 | 0.054 (0.005–0.112) |
0.028 | 0.476 (0.337–0.633) |
<0.001 | 0.203 (0.120–0.293) |
<0.001 | 0.467 (0.116–0.612) |
<0.001 | 0.190 (0.117–0.277) |
<0.001 | ||
| 5-year | 0.463 (0.398–0.628) |
0.01 | 0.087 (0.024–0.147) |
0.01 | 0.445 (0.334–0.648) |
<0.001 | 0.298 (0.192–0.399) |
<0.001 | 0.235 (0.129–0.644) |
<0.001 | 0.266 (0.167–0.364) |
<0.001 | ||
LMR, lymphocyte-to-monocyte ratio; NRI, net reclassification improvement; IDI, integrated discrimination improvement.